Indie Game Schedule I Faces Copyright Dispute Amid Review Bombing Controversy

Schedule I faces allegations of copyright infringement, but its accuser’s games are now facing a wave of negative reviews from fans. Dive into the details of the copyright dispute and Schedule I’s latest updates.

Schedule I Latest Developments

Steam Review Bomb Targets Schedule I’s Copyright Accuser

Indie crime simulator Schedule I has been accused of copyright infringement by Movie Games S.A., creators of the Drug Dealer Simulator series. According to a Polish Press Agency report on April 3, Movie Games S.A. completed a legal review, alleging that Schedule I copied elements of their games’ storyline, mechanics, and user interface.

Although no formal outcome has emerged from the investigation, fans have already taken sides, with Schedule I garnering significant support. On Steam, Drug Dealer Simulator and Drug Dealer Simulator 2 have been hit with a flood of negative reviews, now labeled "Overwhelmingly Negative" and "Mostly Negative," respectively.

Recent reviews criticize Movie Games S.A. for targeting an indie developer while ignoring similar games in the past, accusing them of selective enforcement. This backlash overshadows the Drug Dealer Simulator series’ reputation as a top-tier criminal management game, praised by fans and critics alike.

Schedule I, a co-op crime simulation game, casts players as small-time drug dealers aiming to rise to kingpin status. Launched in Early Access on PC on March 25, it has earned "Overwhelmingly Positive" Steam reviews and ranks as Steam’s second top-selling game, surpassing titles like inZOI, Monster Hunter Wilds, and indie hit R.E.P.O. SteamDB reports a peak of 459,075 concurrent players for Schedule I as of now.

At Game8, we found Schedule I’s Early Access release to be an engaging and immersive experience, akin to a "Breaking Bad" simulator. For our full take on the game, check out the article below!